Spence, Andrew DBusby, JohnMurchie, PeterKunzmann, Andrew TMcMenamin, Úna CColeman, Helen GJohnston, Brian TO'Rorke, Michael AMurray, Liam JIversen, LisaLee, Amanda JaneCardwell, Chris R2019-03-082019-03-082018-07-01Spence, A D, Busby, J, Murchie, P, Kunzmann, A T, McMenamin, Ú C, Coleman, H G, Johnston, B T, O'Rorke, M A, Murray, L J, Iversen, L, Lee, A J & Cardwell, C R 2018, 'Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer : An analysis of two independent population-based databases', International Journal of Cancer, vol. 143, no. 1, pp. 22-31. https://doi.org/10.1002/ijc.312930020-7136ORCID: /0000-0001-9968-5991/work/83704285ORCID: /0000-0002-4865-9061/work/159078241http://hdl.handle.net/2164/12018Acknowledgements We acknowledge collaboration with the Research Applications and Data Management Team lead by Ms Katie Wilde, University of Aberdeen in conducting our study. This research has been conducted using the UK Bio-bank Resource under application number 34374.11312437engSDG 3 - Good Health and Well-beingβ2 agonistsOesophageal cancerBenzodiazepinesCalcium channel blockersNitratesRC0254 Neoplasms. Tumors. Oncology (including Cancer)RC0254Journal article10.1002/ijc.312931431